𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CXCL5 plasma levels decrease in patients with chronic liver disease

✍ Scribed by Frank Tacke; Henning W Zimmermann; Christian Trautwein; Bernd Schnabl

Book ID
108953850
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
342 KB
Volume
26
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Plasma levels of pipecolic acid in patie
Plasma levels of pipecolic acid in patients with chronic liver disease
✍ Hironaka Kawasaki; Tatsuaki Hori; Masako Nakajima; Kenzo Takeshita πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 396 KB πŸ‘ 2 views

Plasma levels of pipecolic acid, which is a minor metabolite of lysine, were determined by high-performance liquid chromatography in 22 patients with chronic liver disease, composed of 6 patients with chronic active hepatitis, 11 with liver cirrhosis and 5 with hepatocellular carcinoma. The plasma l

Carnitine metabolism in patients with ch
Carnitine metabolism in patients with chronic liver disease
✍ S. KrΓ€henbΓΌhl; J. Reichen πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 2 views

with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di